# Interleukin-6 in Plaque Psoriasis and Its Possible Role in Disease Severity

> **NCT07001904** · — · COMPLETED · sponsor: **Tanta University** · enrollment: 50 (actual)

## Conditions studied

- Interleukin-6
- Plaque Psoriasis
- Disease Severity

## Interventions

- **OTHER:** Enzyme-linked immunosorbent assay (ELISA)

## Key facts

- **NCT ID:** NCT07001904
- **Lead sponsor:** Tanta University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2023-11-01
- **Primary completion:** 2024-10-31
- **Final completion:** 2024-10-31
- **Target enrollment:** 50 (ACTUAL)
- **Last updated:** 2025-06-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07001904

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07001904, "Interleukin-6 in Plaque Psoriasis and Its Possible Role in Disease Severity". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT07001904. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*